BioCentury
ARTICLE | Company News

Genetics Co. acquires Abeta assets

June 16, 2003 7:00 AM UTC

Genetics Co. (Schlieren, Switzerland) acquired the assets of Abeta (Heidelberg, Germany), which focuses on diagnostics and therapeutics for Alzheimer's Disease (AD). The cash and stock purchase includ...